Anonymous
Guest
Anonymous
Guest
Leave it to our friends in the west to start the fire! Just aired on TV there. check it out.
http://www.mynews3.com/story.php?id=42450
http://www.mynews3.com/story.php?id=42450
******************
Nope, can't say "Restraint of Trade" but what can be said is "smart". CH and O&M figured out they could make more money selling OEM devices than reprocessed. It was their (CH and O&M) business decision-and a smart one. It is a free country so I guess the distributors saw something in it for them.
Stryker stepped into a pile when they bought Ascent. JNJ is a big ass ant hill. Keep kicking it and they will beat you with a thousand tiny bites. Heaven help the reprocessors if they put Covidien/Valleylab in their crosshairs too.
Device manufacturers didn't add the single use requirement years ago so they make more money, the FDA required it.
And no, the reprocessor doesn't know plenty. They know shit about the device. They have none of the original specs, and any engineer with half a degree from a half assed school knows that specs are not obtainable by measuring a group of devices. They know nothing about the original test procedures that validate a product, and the groovy little secret, is they have no idea when a device has undergone a change by the manufacturer, especially if it's internal.
The reason this market sprouted is understandable with the way JJ rapes the customers with prices. Inflating the price is the real problem. Take care of that and this industry will dissolve.
A few questions...
Would you buy and wear "reprocessed" underwear?
What about a "reprocessed" condom?
What about a "reprocessed" tampon introducer?
Didn't think so.
Now how would you like it if one of the above was purchased at a store and it WAS "reprocessed" yet NOT revealed to you?
Vomit yet?
It's all about full disclosure people.
Reprocessing companies do not know the minute a device is altered, many find out from their customers, for instance the new applied 5mm trocars with the balloons, there is not a 510K on them and the reprocessing company had no idea until customers had less product to purchase back.
Is it true that reprocessed devices have the same or less failure rate than a new device? What's reported to the FDA says its the same, however, reprocessing companies do not know or report all failures. Most hospitals do not take the same approach to a failed OEM product and a reprocessed product.
Is it safe? Of course it's safe, does it gross people out? Yes, but only the ignorant ones.
Stryker has no service or education compared to SterilMed. But currently SterilMed is being held back by EES and not getting the same support Acent received when stryker acquired them.
Stryker does break down the devices, clean and replace the internal components, but they don't keep track of how many times those small internal components have been reprocessed.
SterilMed does not break the device down to the internal components, giving them a larger yield on devices.
I've seen it all, hospitals switching companies, hospitals tainted by OEM pushback and in financial trouble but scared to upset a surgeon, surgeons who are Employeed by the hospital/or own a surgery center being very supportive of reprocessing- it's their dollar being spent and they want the savings too.
FYI- 510K for ligasures and a few valley lab products has already happened.
And both major competitors have been making a lot of lay offs.
Damn right it has. I work for a competitor in the NE, used to work for EES about 3 years ago, and I would conservatively say reprocessing is still around in hospitals, but very few see the financial savings. The OEM just brings the price down to save face, so everyone and their mother is happy and the hospital doesnt need to exert hrs & hrs going through an evaluation. Not to mention I work w/ 3 guys who used to work for Ascent years ago. Money just isn't there.
You forgot to mention that 30% of reprocessed devices don't work! They're guaranteed to be sterile, not functioning...
Did you reread that before posting it? Stop and think about this, do you actually think a company would be in business if 30% of their products didn't work? No, Stryker/Medline or whoever it is would just shut the division down instead of deal with the liability or cost issues. I was with Stryker until a month ago and they actually pay pretty decent. Last year my W2 says $110K and this year I was on pace for $130k before leaving. That opened some great doors and I am now at a new company. Stryker got tired of losing reps so they really increased the commission the past two years. Now reps make a salary + 3% on non-invasive sales, 4.5% on OR sales, & 5.5% on EP sales. Plus annual bonus for hitting quota.
They are a great division, I left because of price erosion from OEM's that are going to make the next 18 months miserable......basically took the easy way out for higher pay.